Viewing Study NCT04519151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-02 @ 9:55 PM
Study NCT ID: NCT04519151
Status: RECRUITING
Last Update Posted: 2023-06-08
First Post: 2020-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sponsor: Sheba Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Ovarian Epithelial View
None Neoplasm of Stomach View
None Ovarian Diseases View
None Genital Neoplasms, Female View
None Ovarian Epithelial Tumor View
None Urogenital Neoplasms View
None Neoplasms, Glandular and Epithelial View
None Ovarian Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian Cancer View
None Platinum sensitive View
None Ovarian Epithelial View
None Neoplasms View
None Genital Neoplasms View